fdps levels Search Results


d-fructose 1,6-bisphosphate sodium salt hydrate (u- 13 c 6)  (Cambridge Isotope Laboratories)
90
Cambridge Isotope Laboratories d-fructose 1,6-bisphosphate sodium salt hydrate (u- 13 c 6)

D Fructose 1,6 Bisphosphate Sodium Salt Hydrate (U 13 C 6), supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fdps+levels/pmc06636998-117-3-14?v=Cambridge+Isotope+Laboratories
Average 90 stars, based on 1 article reviews
d-fructose 1,6-bisphosphate sodium salt hydrate (u- 13 c 6) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
d-fructose 1,6- bisphosphate sodium salt hydrate (u-13c6)  (Cambridge Isotope Laboratories)
90
Cambridge Isotope Laboratories d-fructose 1,6- bisphosphate sodium salt hydrate (u-13c6)

D Fructose 1,6 Bisphosphate Sodium Salt Hydrate (U 13c6), supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fdps+levels/10__7554_slash_elife__45068-305-14-27?v=Cambridge+Isotope+Laboratories
Average 90 stars, based on 1 article reviews
d-fructose 1,6- bisphosphate sodium salt hydrate (u-13c6) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
fdps levels  (Cusabio)
90
Cusabio fdps levels

Fdps Levels, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fdps+levels/pmc03337563-85-4-12?v=Cusabio
Average 90 stars, based on 1 article reviews
fdps levels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
d-[1- 13 c]fructose-1,6-bisphosphate sodium salt, 99% 13 c  (Omicron Biochemicals Inc)
90
Omicron Biochemicals Inc d-[1- 13 c]fructose-1,6-bisphosphate sodium salt, 99% 13 c

D [1 13 C]Fructose 1,6 Bisphosphate Sodium Salt, 99% 13 C, supplied by Omicron Biochemicals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fdps+levels/pmc02584668-222-7-14?v=Omicron+Biochemicals+Inc
Average 90 stars, based on 1 article reviews
d-[1- 13 c]fructose-1,6-bisphosphate sodium salt, 99% 13 c - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
stago-max  (STAGO GmbH)
90
STAGO GmbH stago-max
Impact of co-infections on inflammatory response, coagulation function, and myocardial injury in COVID-19 patients. Co-infections in COVID-19 patients can lead to lymphopenia and neutrophilia, triggering a cytokine storm. This is accompanied by significant elevations in coagulation function markers and cardiac injury biomarkers, all of which are critical factors in disease progression and worsening outcomes. IL-6, interleukin-6; hs-CRP, Hypersensitivity C-reactive protein; SAA, serum amyloid A; PCT, Procalcitonin; <t>APTT,</t> <t>activated</t> prothrombin time; PT, prothrombin time; FIB, fibrinogen; <t>FDP,</t> Fibrinogen degradation products; hs-TnT, Hypersensitive cardiac troponin; LDH, lactic dehydrogenase; HBDH, α Hydroxybutyrate dehydrogenase; IMA, Ischemic modified albumin; AST, aspartate aminotransferase; m-AST, mitochondrialaspartate aminotransferase; CK, creatine kinase; CK-MB, Creatine kinase isoenzyme MB.
Stago Max, supplied by STAGO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fdps+levels/pmc11879825-78-26-30?v=STAGO+GmbH
Average 90 stars, based on 1 article reviews
stago-max - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
fdp fibrinostiika fdp  (Organon Teknika Corporation LLC)
90
Organon Teknika Corporation LLC fdp fibrinostiika fdp
Impact of co-infections on inflammatory response, coagulation function, and myocardial injury in COVID-19 patients. Co-infections in COVID-19 patients can lead to lymphopenia and neutrophilia, triggering a cytokine storm. This is accompanied by significant elevations in coagulation function markers and cardiac injury biomarkers, all of which are critical factors in disease progression and worsening outcomes. IL-6, interleukin-6; hs-CRP, Hypersensitivity C-reactive protein; SAA, serum amyloid A; PCT, Procalcitonin; <t>APTT,</t> <t>activated</t> prothrombin time; PT, prothrombin time; FIB, fibrinogen; <t>FDP,</t> Fibrinogen degradation products; hs-TnT, Hypersensitive cardiac troponin; LDH, lactic dehydrogenase; HBDH, α Hydroxybutyrate dehydrogenase; IMA, Ischemic modified albumin; AST, aspartate aminotransferase; m-AST, mitochondrialaspartate aminotransferase; CK, creatine kinase; CK-MB, Creatine kinase isoenzyme MB.
Fdp Fibrinostiika Fdp, supplied by Organon Teknika Corporation LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fdps+levels/pm22166587-44-4-7?v=Organon+Teknika+Corporation+LLC
Average 90 stars, based on 1 article reviews
fdp fibrinostiika fdp - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Journal: eLife

Article Title: Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation

doi: 10.7554/eLife.45068

Figure Lengend Snippet:

Article Snippet: Chemical compound , D-fructose 1,6-bisphosphate sodium salt hydrate (U- 13 C 6 ) , Cambridge Isotope Laboratories , CLM-8962-PK , .

Techniques: Recombinant, Mutagenesis, Software

Impact of co-infections on inflammatory response, coagulation function, and myocardial injury in COVID-19 patients. Co-infections in COVID-19 patients can lead to lymphopenia and neutrophilia, triggering a cytokine storm. This is accompanied by significant elevations in coagulation function markers and cardiac injury biomarkers, all of which are critical factors in disease progression and worsening outcomes. IL-6, interleukin-6; hs-CRP, Hypersensitivity C-reactive protein; SAA, serum amyloid A; PCT, Procalcitonin; APTT, activated prothrombin time; PT, prothrombin time; FIB, fibrinogen; FDP, Fibrinogen degradation products; hs-TnT, Hypersensitive cardiac troponin; LDH, lactic dehydrogenase; HBDH, α Hydroxybutyrate dehydrogenase; IMA, Ischemic modified albumin; AST, aspartate aminotransferase; m-AST, mitochondrialaspartate aminotransferase; CK, creatine kinase; CK-MB, Creatine kinase isoenzyme MB.

Journal: Frontiers in Immunology

Article Title: Co-infections exacerbate inflammatory responses in COVID-19 patients, promoting coagulopathy and myocardial injury, leading to increased disease severity

doi: 10.3389/fimmu.2025.1522313

Figure Lengend Snippet: Impact of co-infections on inflammatory response, coagulation function, and myocardial injury in COVID-19 patients. Co-infections in COVID-19 patients can lead to lymphopenia and neutrophilia, triggering a cytokine storm. This is accompanied by significant elevations in coagulation function markers and cardiac injury biomarkers, all of which are critical factors in disease progression and worsening outcomes. IL-6, interleukin-6; hs-CRP, Hypersensitivity C-reactive protein; SAA, serum amyloid A; PCT, Procalcitonin; APTT, activated prothrombin time; PT, prothrombin time; FIB, fibrinogen; FDP, Fibrinogen degradation products; hs-TnT, Hypersensitive cardiac troponin; LDH, lactic dehydrogenase; HBDH, α Hydroxybutyrate dehydrogenase; IMA, Ischemic modified albumin; AST, aspartate aminotransferase; m-AST, mitochondrialaspartate aminotransferase; CK, creatine kinase; CK-MB, Creatine kinase isoenzyme MB.

Article Snippet: Additional samples in sodium citrate anticoagulant tubes were used to assess prothrombin time (PT), activated prothrombin time (APTT), fibrinogen (FIB), D-Dimer (DD), and fibrinogen degradation products (FDP) levels with the Stago-Max.

Techniques: Coagulation, Biomarker Discovery, Modification

Comparison of coagulation function biomarker levels in COVID-19 patients. (A) Severe group (n=173) VS. Mild group (n=431); (B) Severe group (n=100) VS. Mild group (n=402) in non-co-infected patients; (C) Co-infected group (n=102) VS. Non-co-infected group (n=502); (D) Co-infected group VS. Non-co-infected group in the mild (co-infected: n=29, non-co-infected: n=402) and severe groups (co-infected: n=73, non-co-infected=100), respectively. n: Total number of patients with available data. All data presented as the mean ± SEM. Differences were tested using unpaired t test. P<0.05 was considered significant. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001; NS, not significant. PT, prothrombin time; APTT, activated prothrombin time; FIB, Fibrinogen; DD, D-Dimer; FDP, Fibrinogen degradation products.

Journal: Frontiers in Immunology

Article Title: Co-infections exacerbate inflammatory responses in COVID-19 patients, promoting coagulopathy and myocardial injury, leading to increased disease severity

doi: 10.3389/fimmu.2025.1522313

Figure Lengend Snippet: Comparison of coagulation function biomarker levels in COVID-19 patients. (A) Severe group (n=173) VS. Mild group (n=431); (B) Severe group (n=100) VS. Mild group (n=402) in non-co-infected patients; (C) Co-infected group (n=102) VS. Non-co-infected group (n=502); (D) Co-infected group VS. Non-co-infected group in the mild (co-infected: n=29, non-co-infected: n=402) and severe groups (co-infected: n=73, non-co-infected=100), respectively. n: Total number of patients with available data. All data presented as the mean ± SEM. Differences were tested using unpaired t test. P<0.05 was considered significant. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001; NS, not significant. PT, prothrombin time; APTT, activated prothrombin time; FIB, Fibrinogen; DD, D-Dimer; FDP, Fibrinogen degradation products.

Article Snippet: Additional samples in sodium citrate anticoagulant tubes were used to assess prothrombin time (PT), activated prothrombin time (APTT), fibrinogen (FIB), D-Dimer (DD), and fibrinogen degradation products (FDP) levels with the Stago-Max.

Techniques: Comparison, Coagulation, Biomarker Discovery, Infection